查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866972

腹部缝合系统市场按产品类型、材料、应用、最终用户和分销管道划分－2025-2032年全球预测

Abdominal Closure System Market by Product Type, Material, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，腹部缝合系统市场规模将达到 3.4654 亿美元，复合年增长率为 8.96%。

关键市场统计数据
基准年 2024 1.7439亿美元
预计年份：2025年 1.9036亿美元
预测年份 2032 3.4654亿美元
复合年增长率 (%) 8.96%

腹部缝合系统全面介绍：概述其临床重要性、技术发展历程、相关人员的角色以及手术安全重点。

腹部缝合系统领域处于外科技术、材料科学和医疗设备工程的关键交叉点，即使是微小的进步也能直接转化为病患预后的改善。本文阐述了临床上对可靠、可重复的腹部缝合解决方案的需求，并概述了推动产品发展的关键技术趋势。透过将医疗设备创新与不断变化的手术技术偏好以及对手术全期安全性的日益重视相结合，本文为临床、监管和商业相关人员相关者的策略决策提供了背景。

与不断发展的临床实践模式一致，本导论部分重点阐述了黏合剂、固定係统、网片设计和缝合技术的逐步改进如何有助于降低併发症发生率、缩短手术时间并促进可预测的术后恢復。此外，本部分还着重强调了外科医生、材料科学家和供应链专家之间的跨学科合作在将实验室成果转化为手术室可用产品方面所发挥的重要作用。最后，本部分阐明了影响产品推广应用週期的典型利益相关人员优先事项，包括安全性、易用性、与不同手术流程的兼容性以及明确的报销或采购理由，从而为后续的深入分析章节奠定基础。

生物材料创新、器械改进、手术偏好转变以及一体化手术模式的推动，正促使腹部缝合技术发生变革性转变。

腹部缝合系统的模式正在发生变化，这得益于技术进步、临床实践的改变以及采购模式的演变。生物材料的创新正在研发出具有更高生物相容性和可客製化降解特性的黏合剂和网片，而器械的小型化和符合人体工学的设计则提高了易用性和手术速度。同时，临床医师的偏好正转向能够缩短手术时间和降低併发症风险的解决方案，这促使研发人员更加重视简化工作流程和提升系统级整合价值。

此外，跨学科合作正在推动生物材料与合成材料相结合的混合解决方案的开发，以平衡生物完整性和机械强度。监管路径和上市后监测要求也在不断调整以适应新的器械和材料组合，这加大了製造商证明其长期安全性和性能的压力。从商业性角度来看，随着供应商寻求更灵活的采购方式，分销和合约模式也在不断演变，数位化采购管道正在拓展传统直销关係之外的管道。这些变化不仅改变了产品蓝图，也重塑了临床证据的生成、检验和应用方式，从而改变了支持产品推广的方式。

分析2025年美国关税对供应链、零件采购、采购流程和医院采购的累积影响

2025年美国关税的累积影响，为腹部缝合系统生态系统的供应链设计、零件采购和采购行为带来了新的转折点。影响进口原料、聚合物组件和成品器械的关税，提高了投入集中风险的可见度，促使製造商重新评估其采购基础，并加快对替代供应商的资格认证。实际上，这意味着对器械组件关税分类的审查力度加大，海关合规活动增多，以及对国际供应商网路中的到岸成本进行更积极的管理。

对于医院和门诊中心而言，下游影响正透过采购週期逐渐显现。采购部门越来越关注总体拥有成本 (TCO) 和合约条款，以便将增加的投入成本转嫁给客户。他们也越来越重视零件来源的透明度，优先考虑那些能够展现强大物流和本地组装能力的供应商。同时，医疗设备製造商的创新团队正在重新评估设计方案，以期透过材料替代来降低关税风险，同时又不影响临床效能。

为了因应关税环境，相关人员正在实施各种缓解措施。製造商正在评估近岸外包方案并实现采购多元化，以减少对单一供应商的依赖。合约条款正在修订，以便与买方分担风险；库存管理方式也在调整，以平衡营运资金和供应连续性。在监管方面，产品团队正在评估组件变更对监管申报和上市后义务的影响，确保在材料替代或生产转移的情况下，产品的安全性和有效性能够保持一致。

最终，关税环境凸显了供应链敏捷性、监管前瞻性和商业性透明度的战略重要性。这些因素共同加速了务实的供应链网络重组，强化了对供应商选择的关注，并提升了在动盪的贸易环境中能够提供稳定供应和可预测总采购成本的产品的价值。

细分市场分析洞察：揭示产品类型、生物材料、临床应用、终端用户和分销管道如何相互交织，进而影响消费者选择。

细分市场分析提供了观点，帮助我们了解临床需求、材料科学和采购管道如何相互交织，共同影响产品的开发和应用。按产品类型划分，腹部缝合解决方案涵盖了黏合剂、夹子、网片系统、缝合钉和缝线，每种类别都有其独特的临床和商业性考虑。黏合剂分为纤维蛋白胶和组织黏合剂，分别针对不同的创伤治疗生物学和应用技术。夹子有金属和聚合物两种材质，选择时渗透性、生物相容性和成本。网片系统分为生物网片和合成网片。生物网膜来自牛或猪的组织，而合成网片通常由聚酯或聚丙烯製成，每种材料在宿主整合性和拉伸性能方面各有不同。缝合钉有手动和电动两种类型，分别体现了对手术效率和易用性的偏好。缝线有可吸收和不可吸收两种材质。可吸收缝线通常由聚乳酸-羟基Polyglactin910 或Polyglycolic乙醇酸製成，而不可吸收缝线则包括尼龙和聚丙烯，选择取决于所需的持续时间和组织反应。

基于材料的分类进一步明确了临床权衡。胶原蛋白和猪细胞外基质等生物材料因其组织重塑的潜力和在污染环境中的相容性而备受重视，而聚酯和聚丙烯等合成材料则提供可预测的机械强度和长期耐久性。基于应用的分类突显了心血管外科、一般外科、妇科和整形外科之间需求的差异，每种外科手术都有独特的机械负荷和感染风险。最终用户（门诊手术中心、医院、专科诊所）的观点会影响产品选择、购买频率和服务预期。门诊手术中心分为独立门诊手术中心和医院附设门诊手术中心，医院分为私立医院和公立医院。专科诊所倾向于寻求具有专业支援方案的利基解决方案。分销管道（直销、分销商、线上平台）影响着商业性覆盖范围和定价策略，并决定培训、循证传播和售后支援的提供方式。整合这些细分维度，可以让相关人员确定特定产品与临床要求、采购惯例和分销现实的契合点，从而为开发重点和上市定位提供资讯。

深入分析美洲、欧洲、中东和非洲以及亚太地区的区域状况，重点在于供应链韧性、临床应用模式和监管差异。

区域趋势将显着影响腹部缝合系统的临床应用路径、监管互动和供应链设计。在美洲，完善的采购流程和采购集团的整合带来了规模经济效益，同时也要求强而有力的临床证据和整体成本优势。该地区公立和私立医疗机构并存的格局，凸显了能够适应不同合约週期和基于价值的讨论的商业模式的重要性。在欧洲、中东和非洲（EMEA），复杂的监管体系和多样化的医疗资金筹措模式要求采取适应性强的监管策略和灵活的商业性方法，以兼顾各国的报销体系和不同的临床实践规范。在许多EMEA市场，当地的註册要求和公共采购流程会影响产品的推广应用时间，因此与各国意见领袖进行有针对性的沟通至关重要。

在亚太地区，部分地区临床应用迅速普及，而其他地区则对成本采购高度敏感，这促使製造商寻求分级产品组合和与区域成本结构相符的製造地。亚太地区多个司法管辖区的监管现代化为创新医疗材料铺平了道路，但标准的差异仍然需要客製化的监管申报和区域特定的临床数据。供应链考量因地区而异。原料产地的接近性、区域生产能力和物流基础设施决定了前置作业时间和库存策略。对于国际供应商而言，区域监管的多样性和不同的临床偏好意味着「一刀切」的方法很少奏效。要实现持续的市场渗透，需要差异化的产品系列、灵活的定价结构和区域特定的临床证据包。总而言之，区域洞察凸显了将监管计划、生产策略和商业性执行与美洲、欧洲、中东和非洲以及亚太地区的独特需求相匹配的必要性。

公司洞察，着重展现竞争优势、产品系列、策略联盟、研发重点和打入市场策略，进而推动其领导力发展。

腹部缝合领域的企业透过丰富的产品组合、材料专业知识和策略性的商业性关係来脱颖而出。业界领导者优先考虑研发投入，以开发更先进的生物材料和器械配置，从而减轻医护人员的负担，同时维持并改善临床疗效。与契约製造、学术机构和临床网路建立伙伴关係和合作对于加速研发週期和获得可靠的临床检验至关重要。拥有多元化产品系列（包括黏合剂、网片、缝合钉和缝合系统）的企业在提供整合解决方案、满足不同外科专科的需求以及占据医院采购平台更大份额方面具有优势。

竞争定位也受到市场进入模式的影响。将直销活动与经销商关係和数位化管道结合的公司，能够触及更广泛的终端用户，同时提供灵活的商业条款，以满足不同机构的采购偏好，包括独立和医院附属的门诊手术中心、私立和公立医院以及专科诊所。附加价值服务，例如外科医生培训计画、临床资料储存库和捆绑式合约选项，能够加强客户关係并提高转换成本。此外，那些建立健全的品管系统和透明供应链可追溯性的公司，正受到采购部门的优先考虑，因为他们需要确保供应的审核和连续性。併购仍是获取新型生物材料专业知识、拓展地域覆盖范围以及加速进入邻近手术领域的有效途径。这些策略选择共同塑造了竞争格局，在这个格局中，技术卓越、商业性适应性和实证实践决定了市场领导地位。

为领导者提供切实可行的建议，以加速创新、加强供应链、简化采购流程，并将临床重点与商业性执行结合。

腹部缝合领域的领导企业应采取一系列切实可行、注重营运的措施，将洞见转化为可衡量的优势。首先，优先投资于生物材料研究，重点在于生物完整性和机械性能的平衡。与临床合作伙伴进行协作式试验设计将提高研究的相关性并加速其应用。其次，实现供应商关係多元化，并考虑近岸外包或双重采购策略，以降低对单一地区的依赖，并减少关税和物流的意外风险。第三，透过整合培训、临床结果数据以及符合医院价值导向采购要求的捆绑式产品和服务，增强商业性提案。

同时，製造商和供应商应更新采购框架，并专注于整体拥有成本、供应透明度和可预测的前置作业时间。纳入允许成本分摊和明确价格上涨条款的合约机制，可以减少投入价格波动带来的摩擦。加强监管准备至关重要：任何材料替代或生产转移都应事先进行严格的等效性测试并与监管机构协商，以避免上市后出现问题。最后，考虑实施数位化工具，透过实践培训、证据摘要和真实世界性能数据来促进临床医生的参与，并收集结果以推动产品持续改进。全面实施这些措施将增强韧性，促进顺利推广，并确保永续的商业性绩效。

调查方法摘要，涵盖研究设计、一手和二手资料收集、专家访谈、检验以及证据综合分析方法。

本研究设计结合了质性研究和全面的二手资料综合分析，建构了多层次的证据基础。主要活动包括：对循环系统、一般外科、妇科和整形外科医生进行结构化访谈；与门诊手术中心和医院的采购和供应链经理进行深入讨论；以及咨询监管机构和生产专家，以了解材料来源和合规性方面的考虑。二手研究纳入了同行评审文献、监管指导文件以及已发布的生物材料和手术结果技术规范，以更好地阐释主要研究的发现。

分析方法强调检验和检验。访谈结果经过主题编码，并与二级资讯来源交叉比对，以识别趋同趋势并发现需要进一步调查的差异。透过供应链映射和组件采购分析，揭示集中风险并评估潜在的缓解策略。检验过程透过与外部专家进行多次迭代审查以及与监管先例交叉比对，确保技术表征的准确性。这种方法将定性分析的深度与系统检验相结合，从而得出可靠且可操作的结论，适用于商业性和临床决策。

总之，我们综合了关键的临床、技术、监管和商业性见解，以指导腹部缝合领域的策略决策和未来重点工作。

最终的综合分析将临床需求、材料科学发展、供应链现状和商业策略融会贯通，形成一套连贯的结论，以指南未来的行动。在所有产品类型中，材料选择和器械人体工学设计仍然是改善手术效果和加速临床接受度的关键因素。关税和贸易环境为策略规划增添了新的维度，使得增强供应链韧性和供应商多元化成为优先事项。美洲、欧洲、中东和非洲以及亚太地区的区域差异需要製定细緻的监管计划和差异化的商业化策略，以满足当地的市场需求。

那些将严谨的研发投入、透明的供应链运作和灵活的商业模式结合的公司，将更有能力满足医疗服务提供者的需求并维持长期合作关係。医疗服务提供者和采购团队应寻求能够提供可预测的供应、清晰的临床证据和灵活的合约选择的伙伴关係。简而言之，事实证明，一种平衡的方法行之有效，该方法能够同时推动创新、增强营运韧性，并实现符合外科团队和医疗系统采购人员实际需求的商业性执行。这种综合观点为优先考虑能够带来持续临床和商业性效益的措施提供了切实可行的基础。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 腹部手术中越来越多地采用带倒刺缝合技术进行快速可靠的筋膜缝合
  • 增加抗菌和防沾黏网片材料的使用，以减少术后感染和沾黏的形成。
  • 机器人辅助腹壁缝合系统的普及提高了手术精度并减轻了外科医生的疲劳。
  • 推出配备感应器的伤口闭合装置，可即时监测伤口张力，进而创伤治疗。
  • 医院感染控制通讯协定和成本分析推动了一次性腹部缝合套件的过渡。
  • 可吸收倒刺缝合线逐渐取代传统的编织缝合线，提高了腹腔镜缝合的效率。
  • 创新闭合系统获得更广泛的监管核准，加速进入亚太和拉丁美洲市场

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的腹部缝合系统市场

  • 黏合式封口
    • 纤维蛋白胶
    • 组织黏合剂
  • 夹子
    • 金属夹
    • 聚合物夹
  • 网格系统
    • 生物网膜
      • 牛源
      • 源自猪
    • 合成网
      • 聚酯纤维
      • 聚丙烯
  • 史泰博
    • 手动输入
    • 电的
  • 缝合线
    • 吸收性
      • Polyglactin910
      • Polyglycolic
    • 不可吸收
      • 尼龙
      • 聚丙烯

9. 按材料分類的腹部缝合系统市场

  • 生物来源
    • 胶原蛋白
    • 猪源性细胞外基质
  • 合成
    • 聚酯纤维
    • 聚丙烯

第十章 依应用分類的腹部闭合系统市场

  • 心血管外科
  • 一般外科
  • 妇科手术
  • 整形外科手术

第十一章 腹部缝合系统市场（依最终用户划分）

  • 门诊手术中心
    • 独立的
    • 医院附属机构
  • 医院
    • 私人的
    • 民众
  • 专科诊所

第十二章 腹部缝合系统市场（依分销管道划分）

  • 直销
  • 经销商
  • 线上平台

13. 各地区腹部缝合系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 腹部闭合系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国腹部缝合系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Johnson & Johnson
    • Medtronic plc
    • B. Braun Melsungen AG
    • 3M Company
    • Cardinal Health, Inc.
    • Smith & Nephew plc
    • Stryker Corporation
    • CONMED Corporation
    • Teleflex Incorporated
    • Baxter International Inc.
Product Code: MRR-CD5A9334D821

The Abdominal Closure System Market is projected to grow by USD 346.54 million at a CAGR of 8.96% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 174.39 million
Estimated Year [2025] USD 190.36 million
Forecast Year [2032] USD 346.54 million
CAGR (%) 8.96%

Comprehensive introduction to abdominal closure systems outlining clinical importance, technology evolution, stakeholder roles, and priorities for surgical safety

The abdominal closure system landscape occupies a critical intersection of surgical technique, material science, and device engineering, where small advances translate directly into improved patient outcomes. This introduction frames the clinical imperative for reliable, reproducible abdominal closure solutions while outlining the major technology vectors that are driving product evolution. By situating device innovation alongside changing procedural preferences and heightened emphasis on perioperative safety, the narrative establishes the context for strategic decision-making across clinical, regulatory, and commercial stakeholders.

To maintain coherence with evolving practice patterns, the introduction emphasizes how incremental improvements in adhesives, fastening systems, mesh design, and suture technology can reduce complication rates, shorten operative time, and contribute to more predictable postoperative recovery. It also highlights the role of multidisciplinary collaboration-between surgeons, materials scientists, and supply chain professionals-in translating laboratory advances into usable products in the operating room. Finally, the section clarifies the stakeholder priorities that typically govern adoption cycles, including demonstrable safety, ease of use, compatibility with diverse surgical workflows, and clarity in reimbursement or purchasing rationale, setting the stage for deeper analytical sections that follow.

Transformative shifts in abdominal closure driven by biomaterials innovation, device refinement, procedural preference evolution, and integrated surgical models

The landscape for abdominal closure systems is shifting under a confluence of technological progress, clinical practice changes, and evolving procurement models. Biomaterials innovation is unlocking adhesives and meshes with enhanced biocompatibility and tailored degradation profiles, while device miniaturization and ergonomics are improving handling and procedural speed. Concurrently, clinician-led preferences are moving toward solutions that reduce operating room time and lower complication risk, prompting developers to place greater emphasis on simplified workflows and integrated system-level value.

In addition, cross-disciplinary collaborations are fostering hybrid solutions that blend biologic and synthetic approaches to balance host integration and mechanical strength. Regulatory pathways and post-market surveillance requirements are also adapting to novel device-material combinations, exerting greater pressure on manufacturers to demonstrate long-term safety and performance. From a commercial perspective, distribution and contracting models are evolving as providers seek more flexible sourcing options and as digital procurement channels expand access beyond traditional direct-sales relationships. Taken together, these shifts are not only altering product roadmaps but are also reshaping how clinical evidence is generated, validated, and deployed to support adoption.

Analysis of the cumulative impact of United States tariff actions in 2025 on supply chains, component sourcing, procurement approaches, and hospital procurement

The cumulative impact of United States tariff actions in 2025 has introduced new inflection points for supply chain design, component sourcing, and procurement behaviour across the abdominal closure ecosystem. Tariff measures affecting imported raw materials, polymer components, and finished devices have increased the visibility of input-concentration risk, prompting manufacturers to re-evaluate sourcing footprints and to accelerate qualification of alternate suppliers. In practice, this has meant closer scrutiny of tariff classifications for device components, increased customs compliance activity, and more active management of landed costs across international supplier networks.

Hospitals and ambulatory centers have felt the downstream effects through procurement cycles, with purchasing teams increasingly focused on total cost of ownership and on contract terms that allow pass-through of increased input costs. Providers are also more likely to request greater transparency on component origin and to favor suppliers that can demonstrate resilient logistics or local assembly capabilities. Meanwhile, innovation teams at device manufacturers are reassessing design choices where material substitution could mitigate tariff exposure without compromising clinical performance.

To navigate the tariff environment, stakeholders are implementing a range of mitigation strategies. Manufacturers are evaluating nearshoring options and diversifying supplier bases to reduce single-source dependencies. Contractual terms are being revised to share risk with buyers, and inventory management practices are being adjusted to balance working capital with supply continuity. On the regulatory side, product teams are weighing the implications of component changes on regulatory filings and post-market obligations, ensuring that any material substitutions or manufacturing transfers retain equivalence in safety and effectiveness.

Ultimately, the tariff context has reinforced the strategic importance of supply chain agility, regulatory foresight, and commercial transparency. The combined effect has been an acceleration in practical supply network redesign, a renewed focus on supplier qualification, and an increased premium on products that can demonstrate consistent availability and predictable total acquiring costs under shifting trade conditions.

Segmentation insights exploring how product categories, biomaterials, clinical applications, end users, and distribution channels converge to shape selection

Segmentation analysis offers a lens to understand how clinical needs, material science, and purchasing channels intersect to shape product development and adoption. When viewed by product type, the universe of abdominal closure solutions spans adhesive closures, clips, mesh systems, staples, and sutures, with each category bringing distinct clinical and commercial considerations. Adhesive closures divide into fibrin sealants and tissue adhesives, which cater to different wound-healing biology and application techniques. Clips are available in metal and polymer variants, where the choice often balances radiopacity, biocompatibility, and cost. Mesh systems bifurcate into biological and synthetic options; biological meshes can be sourced from bovine or porcine tissues, while synthetic meshes are typically polyester or polypropylene, each material offering a different profile for host integration and tensile properties. Staples arrive as manual and powered formats, reflecting preferences for procedural efficiency and ergonomics. Sutures present choices between absorbable and nonabsorbable materials; absorbable threads are often polyglactin 910 or polyglycolic acid, while nonabsorbable options include nylon and polypropylene, decisions that hinge on desired longevity and tissue response.

Material-based segmentation further clarifies clinical trade-offs. Biological materials such as collagen and porcine extracellular matrix are valued for their remodelling potential and compatibility with contaminated fields, whereas synthetic options like polyester and polypropylene provide predictable mechanical strength and long-term durability. Application-driven segmentation highlights divergence in requirement sets across cardiovascular, general, gynecological, and orthopedic surgery, with each area imposing unique mechanical demands and infection-risk profiles. The end-user perspective, spanning ambulatory surgical centers, hospitals, and specialty clinics, influences product selection, purchasing cadence, and service expectations; ambulatory surgical centers include freestanding and hospital-affiliated models, hospitals split between private and public ownership, and specialty clinics often seek niche solutions with focused support packages. Distribution channels-direct sales, distributors, and online platforms-shape commercial reach and pricing dynamics and determine how training, evidence dissemination, and post-sale support are delivered. By synthesizing these segmentation dimensions, stakeholders can identify where a given product aligns with clinical requirements, procurement practices, and distribution realities, thereby informing development priorities and go-to-market positioning.

Regional insights for the Americas, EMEA, and Asia-Pacific emphasizing supply chain resilience, clinical adoption patterns, and regulatory differences

Regional dynamics exert substantial influence on clinical adoption pathways, regulatory interactions, and supply chain design for abdominal closure systems. In the Americas, procurement sophistication and consolidated purchasing groups create both opportunities for scale and pressures for robust clinical evidence and favorable total cost narratives. The region's mix of private and public providers places a premium on commercial models that can accommodate varied contracting cycles and value-based discussions. Europe, Middle East & Africa presents a complex regulatory mosaic and heterogeneous healthcare financing models, demanding adaptable regulatory strategies and flexible commercial approaches that account for national reimbursement schemes and differing clinical practice norms. In many EMEA markets, local registration requirements and public procurement processes shape time-to-adoption and necessitate targeted engagement with national opinion leaders.

Asia-Pacific offers a combination of rapid clinical adoption in certain hubs and cost-sensitive procurement in others, driving manufacturers to pursue tiered product offerings and manufacturing footprints that address regional cost structures. Across Asia-Pacific, regulatory modernization in several jurisdictions has opened pathways for innovative materials, but variability in standards still requires tailored regulatory dossiers and localized clinical data. Supply chain considerations vary across regions: proximity to raw material sources, regional manufacturing capabilities, and logistics infrastructure determine lead times and inventory strategies. For international suppliers, regional regulatory heterogeneity and differing clinical preferences mean that a one-size-fits-all approach is rarely effective; instead, differentiated portfolios, flexible pricing constructs, and region-specific clinical evidence packages are required to achieve sustainable penetration. Overall, regional insights underscore the necessity of aligning regulatory planning, manufacturing strategy, and commercial execution with the unique demands of the Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company insights highlighting competitive positioning, product portfolios, strategic alliances, R&D priorities, and go-to-market strategies that drive leadership

Companies operating in the abdominal closure domain are distinguishing themselves through a blend of portfolio depth, materials expertise, and strategic commercial relationships. Industry leaders prioritize investments in R&D to refine biomaterials and to develop device configurations that reduce clinician burden while preserving or enhancing clinical outcomes. Partnerships and alliances-whether with contract manufacturers, academic centers, or clinical networks-have become central to accelerating development cycles and gaining credible clinical validation. Firms with diversified product portfolios that span adhesives, meshes, staples, and suture systems are better positioned to provide bundled solutions, address cross-surgical needs, and capture a larger share of hospital purchasing frameworks.

Competitive positioning is also shaped by go-to-market models. Companies that combine direct-sales engagement with distributor relationships and digital channels can reach a broader set of end users while tailoring commercial terms to account for the purchasing preferences of freestanding ambulatory surgical centers, hospital-affiliated ASCs, private and public hospitals, and specialty clinics. Value-added services-such as surgeon training programs, clinical data repositories, and bundled contracting options-strengthen customer relationships and create higher switching costs. Additionally, firms that cultivate robust quality systems and transparent supply-chain traceability are gaining preference among procurement teams that demand auditability and continuity of supply. Mergers and acquisitions continue to be tools for acquiring novel biomaterials expertise, expanding geographic reach, and accelerating entry into adjacent procedural areas. Taken together, these strategic choices define a competitive landscape where technical excellence, commercial adaptability, and evidence-based engagement determine market leadership.

Practical recommendations enabling leaders to accelerate innovation, strengthen supply chains, streamline procurement, and synchronize clinical priorities with commercial execution

Leaders in the abdominal closure sector should adopt a set of pragmatic, operationally focused actions to translate insight into measurable advantage. First, prioritize targeted investment in biomaterials research that balances host integration with mechanical performance; working with clinical partners to co-design trials will increase relevance and accelerate adoption. Second, diversify supplier relationships and consider nearshoring or dual-sourcing strategies to reduce dependency on single geographies and to mitigate tariff or logistics shocks. Third, strengthen commercial propositions by integrating training, clinical outcomes data, and bundled offerings that align with hospital value-based purchasing requirements.

In parallel, manufacturers and providers should modernize procurement frameworks to emphasize total cost of ownership, supply transparency, and predictable lead times. Embedding contractual mechanisms that allow for cost-sharing and clear escalation clauses will reduce friction when input prices shift. Regulatory readiness must be elevated: any material substitutions or manufacturing transfers should be preceded by rigorous equivalence testing and regulatory consultation to avert post-market complications. Finally, invest in clinician engagement by providing hands-on training, evidence summaries, and real-world performance data, and consider digital tools to capture outcomes and inform iterative product improvements. These actions, taken together, will enhance resilience, facilitate smoother adoption, and support sustainable commercial performance.

Methodology summary covering research design, primary and secondary data collection, expert interviews, validation, and analytic methods for evidence synthesis

The research design combined primary qualitative inquiry with comprehensive secondary synthesis to produce a multilayered evidence base. Primary activities included structured interviews with clinicians across cardiovascular, general, gynecological, and orthopedic specialties, in-depth discussions with procurement and supply chain leaders from ambulatory surgical centers and hospitals, and consults with regulatory and manufacturing experts to understand material sourcing and compliance considerations. Secondary research incorporated peer-reviewed literature on biomaterials and surgical outcomes, regulatory guidance documents, and publicly available technical specifications to contextualize primary insights.

Analytic techniques emphasized triangulation and validation. Interview findings were coded thematically and cross-referenced with secondary sources to identify convergent signals and to expose areas of divergence requiring further inquiry. Supply chain mapping and component provenance analysis were employed to uncover concentration risks and to evaluate potential mitigation pathways. Validation steps included iterative review sessions with external subject matter experts and cross-checks against regulatory precedents to ensure the accuracy of technical characterizations. The approach balanced qualitative depth with systematic verification to produce robust, actionable insights suitable for commercial and clinical decision-making.

Conclusion synthesizing key clinical, technological, regulatory, and commercial insights to guide strategic decisions and future priorities in abdominal closure

The concluding synthesis brings together clinical imperatives, material science developments, supply chain realities, and commercial strategy into a coherent set of insights to inform next steps. Across product categories, materials choices and device ergonomics remain primary levers for improving surgical outcomes and accelerating clinical acceptance. The tariff and trade environment has added a new dimension to strategic planning, elevating supply chain resilience and supplier diversification as priority initiatives. Regional heterogeneity-spanning the Americas, Europe, Middle East & Africa, and Asia-Pacific-requires nuanced regulatory planning and differentiated commercialization strategies to match local adoption drivers.

Companies that combine disciplined R&D investment, transparent supply chain practices, and adaptive commercial models will be best positioned to meet provider needs and to sustain long-term engagement. Providers and procurement teams, for their part, should seek partnerships that offer predictable supply, clear clinical evidence, and flexible contracting options. In sum, the evidence supports a balanced approach that simultaneously advances technical innovation, strengthens operational resilience, and aligns commercial execution with the practical demands of surgical teams and health system purchasers. This integrated perspective provides a pragmatic foundation for prioritizing initiatives that will yield durable clinical and commercial benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of barbed suture technology for faster secure fascial closure in abdominal procedures
  • 5.2. Increasing integration of antimicrobial and antiadhesion mesh materials to reduce postoperative infections and adhesions
  • 5.3. Surge in robotic assisted abdominal wall closure systems improving precision and reducing surgeon fatigue
  • 5.4. Emergence of sensor enabled closure devices offering real time wound tension monitoring for enhanced healing outcomes
  • 5.5. Shift toward single use disposable abdominal closure kits driven by hospital infection control protocols and cost analysis
  • 5.6. Growing preference for absorbable barbed sutures over traditional braided materials to streamline laparoscopic closures
  • 5.7. Expanding regulatory approvals for innovative closure systems facilitating market entry in Asia Pacific and Latin America

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Abdominal Closure System Market, by Product Type

  • 8.1. Adhesive Closures
    • 8.1.1. Fibrin Sealants
    • 8.1.2. Tissue Adhesive
  • 8.2. Clips
    • 8.2.1. Metal Clips
    • 8.2.2. Polymer Clips
  • 8.3. Mesh Systems
    • 8.3.1. Biological Mesh
      • 8.3.1.1. Bovine
      • 8.3.1.2. Porcine
    • 8.3.2. Synthetic Mesh
      • 8.3.2.1. Polyester
      • 8.3.2.2. Polypropylene
  • 8.4. Staples
    • 8.4.1. Manual
    • 8.4.2. Powered
  • 8.5. Sutures
    • 8.5.1. Absorbable
      • 8.5.1.1. Polyglactin 910
      • 8.5.1.2. Polyglycolic Acid
    • 8.5.2. Nonabsorbable
      • 8.5.2.1. Nylon
      • 8.5.2.2. Polypropylene

9. Abdominal Closure System Market, by Material

  • 9.1. Biological
    • 9.1.1. Collagen
    • 9.1.2. Porcine Extracellular Matrix
  • 9.2. Synthetic
    • 9.2.1. Polyester
    • 9.2.2. Polypropylene

10. Abdominal Closure System Market, by Application

  • 10.1. Cardiovascular Surgery
  • 10.2. General Surgery
  • 10.3. Gynecological Surgery
  • 10.4. Orthopedic Surgery

11. Abdominal Closure System Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Freestanding
    • 11.1.2. Hospital-Affiliated
  • 11.2. Hospitals
    • 11.2.1. Private
    • 11.2.2. Public
  • 11.3. Specialty Clinics

12. Abdominal Closure System Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Platforms

13. Abdominal Closure System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Abdominal Closure System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Abdominal Closure System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Johnson & Johnson
    • 16.3.2. Medtronic plc
    • 16.3.3. B. Braun Melsungen AG
    • 16.3.4. 3M Company
    • 16.3.5. Cardinal Health, Inc.
    • 16.3.6. Smith & Nephew plc
    • 16.3.7. Stryker Corporation
    • 16.3.8. CONMED Corporation
    • 16.3.9. Teleflex Incorporated
    • 16.3.10. Baxter International Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ABDOMINAL CLOSURE SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ABDOMINAL CLOSURE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ABDOMINAL CLOSURE SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICA